Jahan Marcu, Ph.D.
Jahan Marcu, Ph.D., is currently the Director of Research and Development at Green Standard Diagnostics Inc. Dr. Marcu is the Senior Scientist at Americans for Safe Access, and on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM). Jahan Marcu is also one of the auditors for the Patient Focused Certification (PFC) program. He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone.
Before earning his Ph.D., Dr. Marcu worked at the California Pacific Medical Center Research Institute studying the anti-cancer properties of compounds from the cannabis plant (Published in the Journal of Molecular Cancer Therapeutics) and on analytical cannabis research projects in Holland. He is also an author of the American Herbal Pharmacopeia’s Cannabis Monograph and is an auditor for the Patient Focused Certification program. Dr. Marcu was the first recipient of the Billy Martin research award from the International Cannabinoid Research Society.
He effectively translates complex scientific concepts to a lay audience and is developing international networks of key cannabis researchers. He has served as a volunteer for Americans for Safe Access (ASA) since 2003. He has been invited to speak on the subject of cannabinoid science at universities, medical cannabis cooperatives, libraries, and high schools. Dr. Marcu is a contributing author and/or editor of several publications including: O’Shaughnessy’s: The Journal Of Cannabis In Clinical Practice (beyondthc.com), projectCBD.org, the West Coast Leaf (aka the Leaf), the Philadelphia examiner (www.examiner.com) , CannabisNow, and the sensible science blog at freedomisgreen.com. Dr. Marcu is also court qualified cannabis and synthetic cannabinoid expert.